Searchable abstracts of presentations at key conferences in endocrinology

ea0071012 | Chronic complications versus glycaemic variability, time in range and HbA1c in people with type 1 diabetes: sub study of the RESCUE-trial | BES2020

Chronic complications versus glycaemic variability, time in range and HbA1c in people with type 1 diabetes: sub study of the RESCUE-trial

A El Malahi , M Van Elsen , S Charleer , F De Ridder , K Ledeganck , B Keymeulen , L Crenier , R Radermecker , B Lapauw , C Vercammen , F Nobels , C Mathieu , P Gillard , C De Block

Background and aims: So far, HbA1c is the only metric of glucose control showing a strong association with chronic complications. However, it does not reflect short-term glycemic variability nor provides guidance in decreasing risk of hypoglycemia. More widespread use of continuous glucose monitoring (CGM) has changed the way people with type 1 diabetes (T1D) manage their glycemia by providing information about glycemic variability and time spent in different glucose ranges.</...

ea0088016 | Abstracts | BES2022

Mortality-related risk factors of inpatients with diabetes and COVID-19: a Multicentric Retrospective Study in Belgium

T Servais , F Laurent , C Litvine , Groote E De , V Godart , E Repetto , M Ponchon , P Chasseur , L Crenier , Eeckhoudt S Van , J Yango , P Oriot , M Gavriliu , S Rouhard , B Deketelaer , C Bugli , L Belkhir , D Maiter , M.P Hermans , JC Yombi , Laura Orioli

Purpose: We describe the characteristics and prognosis of inpatients with diabetes and coronavirus disease 2019 (COVID-19) in Belgium.Methods: We conducted a multicentre retrospective study during the first wave of the pandemic, from March 1, 2020 to May 6, 2020. Data on admission of patients with diabetes and hospitalized due to confirmed COVID-19 were collected. COVID-19 diagnosis was based on a positive polymerase chain reaction (PCR) test on nasophar...